Cardiovascular Week articles from December 2004

Cardiovascular Week archives from December 2004

Gross mechanical efficiency can be used to evaluate changes in motor function.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described a stair-climbing test for ambulatory assessment of children with cerebral palsy. Researchers in Israel report, "The purpose of [our] study was to develop a stair-climbing...

Hyperpolarization and relaxation decline with hypertension and aging.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described changes in endothelium-derived hyperpolarizing factor in hypertension and aging as a response to chronic treatment with renin-angiotensin system inhibitors. Researchers in...

Cerebral vasculature fails to react to hypoxia during sleep.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated cerebral blood flow response to isocapnic hypoxia during slow-wave sleep and wakefulness. According to recent research from England, "Nocturnal hypoxia is a major...

Cholesterol-synthesizing machinery is well developed in premature infants.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described cholesterol synthesis and de novo lipogenesis in premature infants determined by mass isotopomer distribution analysis. "Premature infants change from placental supply of...

Artificial vasculature device may provide better coronary perfusion than VADs.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described left ventricular and myocardial perfusion responses to volume unloading and afterload reduction in a computer simulation. According to published research from the United...

New scheme for identifying alpha[subscript]1A-adrenoceptor splice variants is proposed.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report provided an update on human alpha[subscript]1-adrenoceptor subtype signaling and genomic organization. According to the report from the United States,...

Cyclosporine A exposure in utero linked to adulthood kidney problems, high BP.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- They are calling for a long-term clinical survey of children born to women who received cyclosporin A therapy during their pregnancy. "The number of pregnant women who receive cyclosporin A (CsA)...

New worries tarnishing arthritis drugs.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- One by one, arthritis drugs that promised to ease pain without causing ulcers are losing their luster. In September, Merck & Co. yanked Vioxx from the market when a trial showed that long-term use...

Branched-chain amino acid supplementation does not alter performance in the heat.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated branched-chain amino acid supplementation and human performance when hypohydrated in the heat. According to a study from the United States, "The serotonin system may...

Consider the effect of anesthesia when measuring circulating blood elements.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the effects of anesthesia and vehicle injection on circulating blood elements in C3H/HeN male mice. Investigators in the United States report, "The induction and...

Consider the presence of anesthetics when studying control of heart rate.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have reported on respiratory sinus arrhythmia in freely moving and anesthetized rats. Investigators in the United States report, "Heart rate increases during inspiration and slows...

Vasopressin and platelet-activating factor interact to provoke ischemia.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described the synergistic interaction of endogenous platelet-activating factor and vasopressin in generating angina in rats. Researchers in Hungary report, "We examined the...

ERK played a role in mediating H2S-induced apoptosis of smooth muscle cells.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. According to a study from...

Genomic response to adrenoceptor activation determined in aortic smooth muscle.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The genomic response to adrenoceptor activation has been characterized in aortic smooth muscle cells. "Vascular adrenoceptors play an important role in vascular physiology and pathophysiology, such...

High glucose levels impair nitric oxide-related VEGF synthesis.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- High glucose levels impair nitric oxide-related VEGF synthesis. According to recent research published in the journal Life Sciences, "synthesis of vascular endothelial growth factor (VEGF), the...

Hypoxia and erythropoietin cause endothelial cells to generate nitric oxide.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Hypoxia and erythropoietin cause endothelial cells to generate nitric oxide. According to a study from the United States, "erythropoietin (EPO), a hypoxia-inducible cytokine, is required for...

Kininogen-deficient developed increased cholesterol without plaque formation.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis. "Brown Norway (BN) and BN Katholiek (BN/Ka) rat strains are both susceptible to develop lesions in...

Outflow location on ventricular assist devices may affect patient response.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described the effects of left ventricular assist device support and outflow graft location upon aortic blood flow. According to a study from the United States, "Although continuous...

Study demonstrated concurrent entrainment of all carotid baroreflex measurements.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated dynamic carotid baroreflex control of the peripheral circulation during exercise in humans. Scientists in the United States report, "We sought to determine the dynamic...

Preclinical data of Antrin to treat vulnerable plaque presented at AHA.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc., (NASDAQ:PCYC) announced preclinical findings demonstrating that Antrin (motexafin lutetium) angiophototherapy leads to regression and stabilization of vulnerable plaques in various...

Transit-time flow probes implanted in rat ascending aortas.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Transit-time flow probes have been successfully implanted in rodent ascending aortas. Scientists in the United States described "the implantation of transit-time flow probes on the ascending aorta...

Anti-inflammatory compounds in middle age may decrease CV events in aging.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Results from a pilot study describe the concomitant presence of polymorphic alleles of interleukin-1 beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial...

Novel element in mock circulation may be helpful for investigating heart valves.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the influence of a nonlinear resistance element upon in vitro aortic pressure tracings and aortic valve motions. According to published research from Germany, "In vitro...

Mitochondrial pathway may be involved in myocyte apoptosis in the heart.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report focused on apoptosome formation and caspase activation in the heart. According to the report from the United States, "Apoptosis is a form of cell death which utilizes energy...

Safety and efficacy of subintimal angioplasty reviewed.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The safety and efficacy of subintimal angioplasty in patients with infrainguinal occlusive disease have been reviewed. "Subintimal angioplasty is a relatively new endovascular approach for the...

Collaboration for aspirin-resistance testing announced.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Corgenix Medical Corp. (CONX) and AspirinWorks, a division of Creative Clinical Concepts, Inc., (CCC), both headquartered in Denver, Colorado, announced that together they have entered into a license...

Estrogen-associated COX-2 pathways may explain heart disease protection.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Heart disease is less pronounced in women than in men as humans age, but this difference narrows after menopause. Some studies have shown that estrogen slows heart disease in mouse models, but the...

Metalloproteinases could influence arterial remodeling in hemodialysis patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients. According to recent research from Poland,...

Epinastine hydrochloride is marketed as having few CNS-depressant side effects.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report focused on epinastine hydrochloride for atopic disease. According to the report from the United States, "Atopic conditions include allergic rhinitis, atopic eczema, allergic...

Incidence and effects of for-field R wave oversensing in implants determined.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The frequency and effects of for-field R wave oversensing (FFRWO) have been determined for cardiac implants used in atrial arrhythmia management. Scientists in Italy conducted a study "to determine...

Chronic atrial flutter is marked by prolonged counter-clockwise conduction times.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent observational study described anatomic and electrophysiological differences between chronic and paroxysmal forms of common atrial flutter and comparison with controls. Researchers in...

Enrollment complete for Cubicin's phase III endocarditis/bacteremia trial.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST), following consultation with the U.S. Food and Drug Administration (FDA), announced that it has completed enrollment of patients in its international phase III...

PF9404C and nitroglycerin show different profiles in causing vasodilation.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report describes the differences in the vascular selectivity and tolerance between the NO donor/beta-blocker PF9404C and nitroglycerin. Scientists in Spain report, "The vascular selectivity...

Lipopolisaccharide treatment leads to down-regulation of cholinergic connections.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the role of nitrinergic connections in central cardiovascular responses mediated by physostigmine infused into posterior hypothalamus. Researchers in Italy report, "In...

Developer of surgical and diagnostic products announces financial results.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Neoprobe Corporation (OTCBB:NEOP) announced consolidated operating results for the third quarter of 2004. Third quarter results included revenues of $1.7 million, representing increases of 46%...

Microcatheter systems developer receives notice from Nasdaq regarding bid price.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cardima, Inc., (Nasdaq SC: CRDM) reported that it has received written notice from Nasdaq that, in accordance with Nasdaq Marketplace Rule 4310(c)(8)(D), the company was provided an additional 180 days,...

CryoCath enters exclusive global partnership.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- CryoCath Technologies, Inc., (CYT), a developer of cryotherapy products to treat cardiovascular disease, has agreed to terms on a partnership that grants ATS Medical (ATSI) co-promotion rights in the...

European drug developer awards $1.4M study to ECG services company.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) (ERES), a provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has been awarded a thorough phase I ECG study...

Eligible women less likely than men to receive implantable defibrillators.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Women who met medical criteria to receive implantable defibrillators (ICDs) to prevent fatal heart rhythms were 41% less likely than men to receive the devices, according to findings of a retrospective...

Freezor MAX obtains FDA approval in the U.S.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- CryoCath Technologies, Inc., announced that its Freezor MAX catheter device has received premarket application supplement approval from the U.S. Food and Drug Administration (FDA), allowing the company...

Montgomery County, Maryland, to require defibrillators in health clubs.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The measure requires clubs to have at least one of the machines on-hand, along with a minimum of one staffer who knows how to work it. Defibrillators give a mild shock to people having heart...

Review focuses on transgenesis and cardiac energetics.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent review of transgenesis and cardiac energetics describes new insights into cardiac metabolism. According to the review published in the Journal of Molecular and Cellular Cardiology,...

Regression equation can provide guidance on equivalence between cardiac markers.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report focused on the relationship and differences between serum cardiac markers according to the level of creatine kinase and the type of myocardial infarction. According to investigators...

Technique may represent a novel therapeutic strategy for heart failure.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Phospholamban ablation by RNA interference increases Ca[superscript]2+ uptake into rat cardiac myocyte sarcoplasmic reticulum. According to a study from Japan, "Phospholarnban (PLB) inhibits SR...

Enzyme, inflammation have role in formation of vulnerable plaque, study shows.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- diaDexus announced findings from a new study that indicate a biological role for Lp-PLA2 (lipoprotein-associated phospholipase A2) in the formation of vulnerable plaque. The data were presented at the...

Low adverse events incidence with sirolimus-eluting coronary stent, study shows.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Data presented at the 2004 American Heart Association Scientific Sessions further documented the low incidence of major adverse cardiac events (MACE) and stent thrombosis (blood clots) associated with...

Mef2c gene is a direct target of Foxh1 transcription factor.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Foxh1 is essential for development of the anterior heart field. "The anterior heart field (AHF) mediates formation of the outflow tract (OFT) and right ventricle (RV) during looping morphogenesis...

Burn trauma may contribute to cardiac contractile dysfunction.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Burn trauma alters calcium transporter protein expression in the heart. According to published research from the United States, "We have shown previously that burn trauma produces significant...

Changes in isozyme activities, CaM concentration may affect muscle contractility.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscles of cardiomyopathic hamsters. Investigators in Japan report,...

Company says implantable defibrillators are cost-effective treatment for heart failure patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Medtronic announced that additional scientific data demonstrate that implantable cardioverter-defibrillators (ICDs) are a cost-effective therapy for heart failure patients. In March 2004, results...

Company updates preclinical findings for synthetic vascular graft.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Kensey Nash Corporation presented results from preclinical research on its synthetic vascular graft at the most recent American Heart Association's Scientific Sessions. The company said its findings...

Findings may provide insight into long-term effects of alpha[subscript]1-AR antagonists.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Doxazosin treatment causes differential alterations of alpha[subscript]1-adrenoceptor subtypes in the rat kidney, heart and aorta. Scientists in the United States report, "We have previously...

Microvolt T-wave alternans tested in non-ischemic patient population.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Cambridge Heart, Inc., (OTCBB:CAMH) presented positive scientific evidence at the annual American Heart Association meeting that demonstrates the efficacy of Microvolt T-wave alternans (MTWA) testing...

PTH1R-mediated mechanisms may protect against CV stress-induced responses.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Intravenous delivery of PTH/PTHrP type 1 receptor cDNA to rats decreases heart rate, blood pressure, renal tone, renin angiotensin system, and stress-induced cardiovascular responses. Scientists in...

Pharmaceutical company announces results of heart disease risk study.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- LipoScience announced the results of a major study confirming that the number of LDL particles (LDL-P) measured by nuclear magnetic resonance (NMR) spectroscopy provides better prediction of heart...

Pharmaceutical company comments on results of coronary artery disease study.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals reported that data from the Prevention of Events with Angiotensin-Converting-Enzyme Inhibitors (PEACE) trial released at the recent American Heart Association meeting failed to...

Pharmaceutical company reports on atherosclerosis clinical trail.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals commented on the results of the ARBITER 2 study, which was conducted by Walter Reed Army Medical Center and presented during the 2004 Scientific Sessions of the American Heart...

Research shows generic statin drugs produce same results as brand-name counterparts.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- At the most recent American Heart Association Scientific Sessions, researchers from Kaiser Permanente presented data that showed patients who use a generic statin drug rather than its brand-name...

Review summarizes advances made on the regulation of cardiac ion channels.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent review described the role of modified leucine zipper motifs in the regulation of cardiac ion channels by signaling complexes. According to the review from the United States, "Modulation of...

Review summarizes knowledge about arrhythmic disorders that cause sudden death.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The molecular genetic basis of sudden cardiac death was the focus of a recent report. According to the review published in the journal Pediatric Clinics of North America, "This article outlines the...

Selective delipidation process used to help remove cholesterol from cells.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Lipid Sciences announced that researchers have successfully used its "selective delipidation" process to create a modified form of HDL that is known to be more effective in reverse cholesterol...

Simultaneous activation of JNK and p38 by MLK7 may affect cardiac decompensation.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Transgenic mice with cardiac-specific over-expression of MLK7 have increased mortality when exposed to chronic beta-adrenergic stimulation. According to recent research from the United States,...

Study shows benefits of blood pressure treatment.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Results announced at the recent American Heart Association meeting showed that the life-saving benefits of perindopril (Coversyl), the angiotensin-converting enzyme (ACE) inhibitor used in the European...

Study shows differences in cardiovascular risk among cox-2 inhibitors.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Research published in a recent issue of Atherosclerosis showed cox-2 inhibitor Vioxx caused biochemical changes that contribute to the development of heart disease, while Celebrex, another cox-2...

Superoxide dismutase activity was enhanced in the heart cytosol of rats.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Regucalcin increases superoxide dismutase activity in the heart cytosol of normal and regucalcin transgenic rats. Researchers in Japan report, "The effect of regucalcin, a regulatory protein in the...

Tethering of protein kinase A may be essential for cardiac muscle contraction.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent review focused on A-kinase anchoring proteins that target protein kinase A in the heart. "There is increasing evidence that subcellular targeting of signaling molecules is an important...

TnT may contribute to the higher tolerance of slow muscles to stress conditions.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Troponin T isoforms alter the tolerance of transgenic mouse cardiac muscle to acidosis. According to recent research published in the journal Archives of Biochemistry and Biophysics, "Troponin T...

Xenon anesthesia impairs partial rebreathing-based cardiac output assessment.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Xenon anesthesia significantly lowers the accuracy of cardiac output (CO) assessment using partial CO[subscript]2 rebreathing. CO "determination based on partial CO[subscript]2 rebreathing has...

Atorvastatin is safe, effective for dyslipidemia in hemodialysis patients.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients. Scientists in Japan...

Postoperative fibrinolysis in pericardial cavity characterized.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Fibrinolytic activity in the pericardial cavity after cardiopulmonary bypass surgery has been characterized. "Aprotinin is frequently administered systemically in patients undergoing...

WonderLab museum exhibit alerts mom to son's heart condition.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A trip to a children's science museum turned out to be quite a day of discovery for a 5-year-old boy after an exhibit alerted his mother to her son's possible heart condition. The WonderLab...

Non-critical pacemaker-induced interference in video capsule endoscopy reported.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Non-critical pacemaker (PM)-induced interference in video capsule endoscopy reported. "The wireless capsule video endoscopy is useful in patients with occult blood loss, but is contraindicated" in...

Thrombogenic effects of novel continuous flow axial pump determined.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The thrombogenic effects of a novel continuous flow axial pump have been determined. "Ventricular assist device (VAD) implantation is associated with impaired primary hemostasis and thromboembolic...

Addition of INTEGRILIN provides superior platelet inhibition with stenting.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc., (NASDAQ:MLNM) announced that in the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR Platelets) trial, the addition of INTEGRILIN, a...

Angiotensin II-responsive genes identified in adrenocortical cells.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A number of angiotensin II (ANG II)-responsive genes have been identified in human adrenocortical cells. "Evidence for the dysregulation of aldosterone synthesis in cardiovascular pathophysiology...

Data confirms enzyme's potential as a target for cardiovascular diagnosis.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- High levels of an enzyme - lipoprotein-associated phospholipase A2 (Lp-PLA2) - believed to trigger a cascade of inflammatory events in atherosclerosis can independently predict increased risk of stroke,...

Nanobacterial link to abnormal calcification described in newly released book.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Nanobac Life Sciences, Inc., (OTCPK:NNBP) announced the release of The Calcium Bomb, a book that gives general audiences a view of the nanobacterial link to abnormal calcification affecting millions of...

Protein is an independent risk marker for kidney and cardiovascular disease.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Data published in the November 2004 supplement to the International Society of Nephrology's Journal, Kidney International, showed the predictive power of albuminuria as a risk marker and therapy target...

Utility of drug-eluting stents reviewed.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- The utility of drug-eluting stents in the treatment of cardiovascular disease has been reviewed. "Current treatment options for acute coronary syndromes as well as chronic stable angina often...

Study analyzes weather patterns and hospitalizations.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- A recent report described weather changes associated with hospitalizations for cardiovascular diseases and stroke in California, 1983-1998. According to published research from the United States,...

Walnuts show multiple new heart health benefits.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Results of a new study from Pennsylvania State University show that consuming walnuts significantly reduces inflammatory markers for cardiovascular disease - specifically, C-reactive protein and harmful...

Urantide should be considered a low efficacy partial agonist.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors. "Urotensin-II is the natural ligand of the UT receptor. This novel system is involved in the...

Corticosteroids are effective in reducing serum CRP levels in patients with COPD.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. According to published research from Canada, "Systemic...

Smoking cessation can improve survival among severe COPD patients, study shows.
December 6, 2004... 2004 DEC 6 - (NewsRx.com & NewsRx.net) -- Patients with severe chronic obstructive pulmonary disease (COPD) who stop smoking may be able to improve their rate of survival, despite the severity of their lung disease, according to a new study...